Analyzing the trends and forecasting Global Liver Cancer Therapeutics Analyzing the trends and forecasting Global Liver | Page 2
According to the report “Global Liver Cancer Therapeutics Market,” published by Market
Data Forecast, the global market is projected to reach USD 884.14 million by 2021 from USD
572 million in 2016, at a CAGR of 9.1%.
Liver cancer begins in the cells of your liver which is a football-sized organ in the right upper
portion of the abdomen. There are many types of cancers that can form in the liver, the
most common type being hepatocellular carcinoma. During the treatment of this condition,
the most important things to consider include the stage of the cancer as well as the health
of rest of your liver.
Request Free Sample: http://www.marketdataforecast.com/market-reports/global-liver-
cancer-therapeutics-market-836/request-sample
Though prevention is the best cure, several new detection methods are being studied
amongst which DKK1 is promising. Researchers are also studying methods to predict
whether the cancer may come back by studying the liver cells through genetic sampling.
Liver transplant, Chemotherapy, Radiation Therapy and Targeted therapy are some of the
common treatments while Virus therapy by the use of virus JX-594 is a newer approach.
The factors influencing the Global Market for Liver Cancer Therapeutics Market, either
positively or negatively are presented in the DROC analysis. Major drivers for liver cancer
therapeutics market are increasing aging population, more unmet requirements for the
treatment of liver cancer, drug inventions with respect to the cancer, increasing government
initiatives, rising occurrences of cancer and mounting health care expenditure. However,
factors such as stringent regulatory processes, high capital investments, low success rate in
clinic trials for drugs and low approachability in remote areas are hindering the growth of
liver cancer therapeutics market.
For granular level understanding, the Liver Cancer Therapeutics Market is segmented based
on the following categories with Market Size Estimations and Y-o-Y Forecasts presented for
each sub-segments.
1) By Type
Primary
Secondary
Benign Liver growths
2) By Therapeutics
Hepatocellular Carcinoma
Cholangio carcinoma